As of November 14, 2026, Glycomimetics Inc has reported one exit or restructuring plan to the SEC on Form 8-K under Item 2.05, the latest filed on July 30, 2024. No WARN notice under its name is on file in the states covered here (Form 8-K, July 30, 2024).
10 companies announced layoffs this week, 1 had other signals.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| UPWORK, INC | announced layoffs | |
| PVH CORP. /DE/ | announced layoffs | |
| Battelle | filed a layoff notice for 15 employees | |
| TidalHealth Primary Care | filed a layoff notice for 5 employees | |
| Phunware, Inc. | announced layoffs |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of Glycomimetics Inc.
Free to see. No signup.
People from Glycomimetics Inc who say they are open to work
Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.
Loading the list…
Affected by the Glycomimetics Inc layoff? Add yourself to the open-to-work list, free
Your entry
Glycomimetics Inc reported 1 exit or restructuring plan on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did Glycomimetics have layoffs in 2024? What its filings say
Glycomimetics Inc (CIK 1253689) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K filed 2024-07-30
This filing reports Item 2.05, and its section states none of employees affected, share of workforce, locations, charges or timing in a single sentence. The full text is in the filing.
Also on the record for Glycomimetics Inc
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 27, 2026 | Stake report, Schedule 13G, by BlackRock, Inc. | 5.6% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by BALYASNY ASSET MANAGEMENT L.P. | 6.03% of the class | 5%+ stakes | Source |
| July 20, 2026 | Stake report, Schedule 13D/A, by Fairmount Funds Management LLC | 16.52% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G, by Balyasny Asset Management L.P. | 5.48% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by TANG CAPITAL MANAGEMENT, LLC | 4.21% of the class | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G, by Vestal Point Capital, LP | 5.4% of the class | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by Venrock Healthcare Capital Partners III, L.P. | 9.5% of the class | 5%+ stakes | Source |
| February 5, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 15% of the class | 5%+ stakes | Source |
| December 11, 2025 | Stake report, Schedule 13G, by ForGrowth III PA B.V. | 6.1% of the class | 5%+ stakes | Source |
| December 8, 2025 | Stake report, Schedule 13D/A, by Fairmount Funds Management LLC | 18.53% of the class | 5%+ stakes | Source |
| October 14, 2025 | Stake report, Schedule 13G/A, by 1Globe Capital LLC | 10.3% of the class | 5%+ stakes | Source |
| October 9, 2025 | Stake report, Schedule 13G, by TANG CAPITAL MANAGEMENT, LLC | 5.04% of the class | 5%+ stakes | Source |
Keep reading
More on Glycomimetics Inc and the records around it.
Glycomimetics Inc elsewhere on the record
- 5%+ stake filings Oct 2026
- Who owns it
Companies that share a holder
- 1Globe Capital LLC also filed stake reports on 1 other company: SINOVAC BIOTECH LTD (Sep 2025)
- ForGrowth III PA B.V. also filed stake reports on 4 other companies: Aura Biosciences, Inc. (Oct 2026), Vor Biopharma Inc. (Dec 2025), Astria Therapeutics, Inc. (Nov 2025)
- Fairmount Funds Management LLC also filed stake reports on 14 other companies: Mentari Therapeutics, Inc. (Nov 2026), Alaunos Therapeutics, Inc. (Oct 2026), SPYRE THERAPEUTICS, INC. (Oct 2026)
Watch Glycomimetics Inc
Get an email when Glycomimetics Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Glycomimetics Inc?
Want the whole picture on Glycomimetics Inc?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Glycomimetics Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Glycomimetics Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 16 records.
Tools for this story
Each opens in a new tab, filled in for Glycomimetics Inc. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Related
- Ginkgo Bioworks Holdings, Inc.: 3 SEC filings, Aug 2024 layoff notice within 90 days (2024-08-08)
- Heliogen, Inc.: 2 SEC filings, Aug 2024 layoff notice within 90 days (2024-08-06)
- Warner Music Group Corp.: 2 SEC filings, Sep 2024 layoff notice within 90 days (2024-09-19)
Who owns Crescent Biopharma, Inc.? Owners, funding and legal record
Cite this page
https://mentionfox.com/layoffs/glycomimetics